• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    First Wave Announces Final Patient Dosed Ph2 SPAN Trial Adrulipase Formulation

    GLOBENEWSWIRE

    First Wave BioPharma Reaches Enrollment Target for Phase 2 SPAN Adrulipase Trial

    GLOBENEWSWIRE

    First Wave Completes Screening For PII Span Adrulipase Trial in Cystic Fibrosis

    GLOBENEWSWIRE

    First Wave Biopharma Exceeds 50% Enrollment Target for Phase 2 Span Adrulipase

    GLOBENEWSWIRE

    First Wave Announces First Patient Dosed in Phase 2 SPAN Trial of Adrulipase

    GLOBENEWSWIRE

    First Wave Announces PII Adrulipase Trial Data to be Presented at DDW

    GLOBENEWSWIRE

    First Wave Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial

    GLOBENEWSWIRE

    First Wave Announces Initiation of PII Trial Investigating Enhanced Adrulipase

    GLOBENEWSWIRE

    First Wave Announces Expansion of Adrulipase Intellectual Property Portfolio

    GLOBENEWSWIRE

    First Wave BioPharma Provides Update on IND Filing For PII Trial of Adrulipase

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.